Skip to main content

Table 1 Baseline characteristics of study participants

From: Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients

 N = 74
Age (years)53.9 ± 11.8
Male, n (%)47 (63.5)
Duration of PD (months)30.0 (16.0–96.0)
Cases of ESRD, n (%)
 Diabetic kidney disease21 (28.4%)
 Hypertensive nephrosclerosis19 (25.7%)
 Glomerulonephritis17 (23.0%)
 Polycystic kidney disease3 (4.1%)
aOthers3 (4.1%)
 Unknown11 (14.9%)
Diabetes mellitus, n (%)21 (28.4)
Cardiovascular disease, n (%)10 (13.5)
Ever-smokers, n (%)29 (39.2)
Lipid-lowering therapy, n (%)28 (37.8)
Systolic blood pressure (mmHg)133.7 ± 21.5
Diastolic blood pressure (mmHg)75.0 ± 11.6
Body mass index (kg/m2)23.1 ± 2.8
Hemoglobin (g/L)104 ± 11
Glucose (mmol/L)5.3 ± 2.4
Blood urea nitrogen (mmol/L)7.4 ± 2.1
Creatinine (μmol/L)972.4 ± 371.3
Albumin (g/L)35 ± 5
Triglyceride (mmol/L)1.3 ± 0.8
Total cholesterol (mmol/L)4.3 ± 0.9
LDL cholesterol (mmol/L)2.4 ± 0.7
HDL cholesterol (mmol/L)1.1 ± 0.3
Calcium (mmol/L)2.2 ± 0.2
Phosphorous (mmol/L)1.7 ± 0.5
Total Kt/V urea (per week)2.1 ± 0.4
nPCR (g/kg/day)0.97 ± 0.17
hs-CRP (mg/L)0.96 (0.62–2.10)
sST2 (ng/mL)75.0 ± 26.6
sLR11 (ng/mL)16.4 ± 4.8
  1. Data are expressed as mean ± standard deviation, median (interquartile range), or number of patients (percent)
  2. Abbreviations: hs-CRP high-sensitivity C-reactive protein, HDL high-density lipoprotein, Kt/V urea fractional urea clearance, LDL low-density lipoprotein, nPCR normalized protein catabolic rate, PD peritoneal dialysis, sLR11 soluble form of low-density lipoprotein receptor relative with 11 ligand-binding repeats, sST2 soluble form of suppression of tumorigenicity 2
  3. aOthers: interstitial nephritis, obstructive uropathy, or post status of nephrectomy